Company Directory

Pharmaceutical formulation development and clinical manufacturing services

SGS Quay Pharma is a contract development and manufacturing organisation providing formulation development, analytical services, and clinical trial manufacturing for pharmaceutical and biotechnology companies. The company specialises in dosage form design for APIs with challenging solubility and bioavailability profiles, and in modified and controlled release formulations. Operating from a MHRA and FDA-approved facility in North Wales, it supports clients from preclinical stage through to Phase III and commercial manufacture.

Contract isolation and purification of high-value compounds using HPCCC

BioExtractions Wales is a contract extraction and purification company operating from a 10,000 sq ft facility in Tredegar, South Wales. The company provides isolation and purification services to the pharmaceutical, agrochemical, chemical, and food industries using High Performance Counter Current Chromatography, membrane filtration, and supercritical CO2 extraction. Its HPCCC systems enable separation of natural products, peptides, and synthetic molecules from gram to kilogram scale, isolating multiple target compounds in a single pass.

Biopharmaceutical group distributing and developing cannabis-based medicines

GROW Group is a biopharmaceutical company focused exclusively on cannabis-based medicines, operating through complementary distribution and research divisions. Its UK distribution arm, Grow Group UK, is a licensed GMP specials manufacturer supplying prescribed cannabinoid medicines to patients via specialist physicians. Its R&D division, GROW Biotech, develops cannabinoid extraction, purification, and delivery technologies at its Harpenden laboratory. The group serves patients, prescribers, and international cannabis producers, and holds patents on novel cannabinoid processing methods.

European specialty pharma focused on gastroenterology and hepatology

Norgine is a European specialty pharmaceutical company developing, manufacturing, and commercialising medicines across gastroenterology, hepatology, and cancer supportive care. Founded in 1906 and privately owned, the company markets a portfolio of specialty pharmaceutical products and medical devices across Europe, Australia, and New Zealand. Its primary UK manufacturing and R&D site in Hengoed, Wales employs over 600 people and produces approximately 50 million packs of medicines annually. Norgine supplements its internal pipeline through selective in-licensing partnerships.

Animal health medicines and APIs manufactured for global markets

Elanco UK is the principal UK subsidiary of Elanco Animal Health Incorporated, a global animal health company developing and manufacturing products for farm animals and pets. Its primary UK manufacturing site in Speke, Liverpool produces fermentation-derived active pharmaceutical ingredients and finished veterinary medicines for global distribution, representing an estimated $160–180 million in annual farm animal product revenues. The Speke site has operated as a biopharmaceutical manufacturing facility since the 1950s, originally established by Eli Lilly.

Chemistry-led CRO and CDMO for pharmaceutical and diagnostics R&D

High Force Research is an independent chemistry CRO and CDMO providing synthetic chemistry, process development, and GMP manufacturing services to the pharmaceutical, biotech, and diagnostics industries. Services span route design, complex synthesis, scale-up, and analytical development through to regulatory-grade manufacture of APIs and intermediates. Capabilities include nucleoside chemistry, PROTAC synthesis, peptide chemistry, and imaging agent development. The company operates MHRA-certified GMP laboratories in Bowburn, Durham, with a dedicated R&D hub at NETPark, Sedgefield.

Integrated chemistry and development CRO for small molecules

CatSci is a Cardiff-headquartered contract research organisation providing integrated chemistry, analytical, and development services to biotech and pharmaceutical companies. Founded in 2010 by former AstraZeneca scientists, the company offers process chemistry, analytical development, solid-state and preformulation science, HPAPI development, and preparative purification across the drug development lifecycle. Capabilities have expanded to include oligonucleotide and peptide development. CatSci operates across 14 laboratories in Cardiff, Nottingham, and Strasbourg, serving over 100 biotech and pharma partners globally.

API development and manufacturing for pharmaceutical drug substances

Aptuit is a pharmaceutical chemical development and manufacturing site operating as part of Evotec's API and drug product network. The company develops and manufactures active pharmaceutical ingredients for small molecule drugs, offering route scouting, process development and scale-up, polymorph screening, analytical development and stability studies. Operating MHRA-registered GMP pilot plants and kilo-scale laboratories, it supports pharmaceutical and biotech clients through preclinical and clinical development into commercial-scale API supply.

Integrated drug development, formulation and Phase I clinical services

Quotient Sciences is a contract research, development and manufacturing organisation providing integrated drug development services to pharmaceutical and biotech companies. Its proprietary platform combines drug product formulation, clinical trial manufacturing, and Phase I clinical testing within a single programme, reducing development timelines by up to 12 months. Services span candidate selection through to commercial supply, with specialist expertise in small molecule formulation, solubility enhancement, modified release, and sterile fill/finish.

Custom radiolabelling and integrated small molecule drug discovery services

Eurofins Selcia is a contract research organisation specialising in custom carbon-14 and stable isotope radiolabelling, GMP radiolabelled API manufacturing, and integrated small molecule drug discovery. Its radiochemistry services support preclinical and clinical ADME studies, human mass balance trials, dermal penetration and environmental fate studies. Drug discovery capabilities include medicinal chemistry, fragment screening, and work on peptidyl-prolyl isomerase targets. The company serves pharmaceutical, biotechnology, agrochemical and academic clients globally.

Integrated drug discovery, development and GMP manufacturing CRO

Concept Life Sciences is a contract research organisation delivering integrated drug discovery, development and GMP manufacturing services across facilities in Chapel-en-le-Frith, Edinburgh, Dundee and Sandwich. Its capabilities span medicinal chemistry, translational biology, ADME/DMPK, toxicology and GxP-compliant analytics, supporting programmes from early hit identification through to API manufacturing at multi-kilogram scale. With over 25 years of heritage and more than 230 scientists, the company has advanced 28 drug candidates to clinic and serves pharmaceutical and biotechnology clients globally.

Bioanalytical, DMPK and analytical sciences CRO for drug development

Resolian UK is a contract research organisation specialising in bioanalysis, drug metabolism and pharmacokinetics, and analytical sciences services for pharmaceutical and biotechnology clients. Operating from purpose-built laboratories in Fordham, Cambridgeshire and Sandwich, Kent, the company delivers GxP and non-GMP bioanalytical services including LC-MS/MS small and large molecule analysis, immunogenicity and biomarker assays, and GMP chemistry, manufacturing and controls analytical testing across all phases of drug development.